Literature DB >> 29315286

ALK inhibitors in non-small cell lung cancer: how many are needed and how should they be sequenced?

Alice T Shaw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29315286

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

1.  Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.

Authors:  Elif Karaca Atabay; Carmen Mecca; Qi Wang; Chiara Ambrogio; Ines Mota; Nina Prokoph; Giulia Mura; Cinzia Martinengo; Enrico Patrucco; Giulia Leonardi; Jessica Hossa; Achille Pich; Luca Mologni; Carlo Gambacorti-Passerini; Laurence Brugières; Birgit Geoerger; Suzanne D Turner; Claudia Voena; Taek-Chin Cheong; Roberto Chiarle
Journal:  Blood       Date:  2022-02-03       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.